Table 3.
Haplotype |
Frequency (%)
|
Diplotype |
Frequency (%)
|
Odds ratios
|
P-value | ||
---|---|---|---|---|---|---|---|
Case | Control | Case | Control | 95% confidence intervalsa | |||
XRCC3 (rs861539–rs1799796–rs861537–rs1799794)(Ppermutation test = 0.001) | |||||||
CAGG | 38.6 | 45.3 | CAGG/CAGG | 20.3 | 27.3 | 1 | |
CGAA | 36.7 | 31.3 | CAGG/CGAA | 30.2 | 31.5 | 1.21 (0.84–1.74) | 0.311 |
CAGA | 14.5 | 12.2 | CGAA/CGAA | 15.4 | 10.4 | 1.93 (1.21–3.07) | 0.006 |
TAAA | 5.5 | 4.7 | CAGA/CAGG | 11.0 | 12.1 | 1.33 (0.82–2.15) | 0.245 |
Othersb | 4.7 | 6.5 | CAGA/CGAA | 13.6 | 10.0 | 1.82 (1.13–2.96) | 0.015 |
CAGG/TAAA | 5.7 | 3.5 | 2.07 (1.05–4.08) | 0.036 | |||
CAGA/TAAA | 1.4 | 1.1 | 3.11 (0.93–10.35) | 0.065 | |||
Othersc | 2.4 | 4.1 | 0.68 (0.30–1.54) | 0.352 | |||
XRCC4 (rs3734091–rs1056503)(Ppermutation test = 0.013) | |||||||
CG | 70.8 | 66.8 | CG/CG | 49.1 | 44.1 | 1 | |
CT | 22.9 | 27.9 | CG/CT | 34.5 | 39.4 | 0.76 (0.56–1.02) | 0.067 |
AG | 4.5 | 3.3 | CG/AG | 6.9 | 4.6 | 1.39 (0.76–2.52) | 0.285 |
AT | 1.8 | 2.0 | CT/CT | 4.2 | 5.7 | 0.67 (0.35–1.27) | 0.220 |
CG/AT | 4.1 | 4.2 | 0.63 (0.33–1.21) | 0.164 | |||
Others | 1.2 | 2.0 | 1.10 (0.35–3.46) | 0.876 |
Abbreviations: XRCC3, X-ray repair cross-complementing group 3; XRCC4, X-ray repair cross-complementing group 4.
Bold numerals: A P-value of <0.05 was considered statistically significant.
Adjusted by age, gender, education, family history of lung cancer, smoking status, environmental tobacco smoke, and mental and marital status.
Frequency <5%.
Frequency <2%.